Diaz v. Teva Pharmaceuticals USA, Inc. et al
Consolidated
Lead case: 1:20-md-02974
Lead case: 1:20-md-02974
Georgia Northern District Court | |
Judge: | Leigh Martin May |
Case #: | 1:23-cv-01700 |
Nature of Suit | 367 Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability |
Cause | 28:1332 Diversity-Product Liability |
Case Filed: | Apr 17, 2023 |
Terminated: | Apr 17, 2023 |
Last checked: Saturday Oct 14, 2023 4:50 AM EDT |
Defendant
CooperSurgical, Inc
|
|
Defendant
Teva Branded Pharmaceutical Products R&D, Inc.
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
|
|
Defendant
Teva Women's Health LLC
|
|
Defendant
The Cooper Companies, Inc.
|
|
Plaintiff
Marilina Diaz
|
Represented By
|
Docket last updated: 6 hours ago |
Tuesday, December 17, 2024 | ||
utility
Submission to District Judge
Tue 12/17 10:42 AM
Submission of5 MOTION to Dismiss , to District Judge Leigh Martin May. (bnp) |
||
Friday, November 15, 2024 | ||
8 | 8
2
pgs
order
Order
Mon 11/18 7:48 PM
ORDER: Defendants' Consent Motion to Revise Leadership Structure for MDL Proceedings, Doc. No. 731, is GRANTED. Therefore, the Clerk is directed to substitute Kasey M. Adams, Esq., for Tara L. Blake, Esq., as Co-Lead Counsel for the Cooper Defendants in this action and in all associated cases. (Second Copy of 732 in 1:20-md-02974-LMM. Entered in member cases 1:22-cv-1028 through 3:20- cv-194.) Signed by Judge Leigh Martin May on 11/15/2024. (tht) |
|
7 | 7
1
pgs
order
Order
Mon 11/18 1:35 PM
ORDER granting (730 in 1:20-md-02974-LMM) Tara L. Blake's unopposed motion to withdraw as counsel of record for Defendants CooperSurgical, Inc. and The Cooper Companies, Inc. Signed by Judge Leigh Martin May on 11/15/2024. (Second Copy of 732 in 1:20-md-02974-LMM. Entered in member cases 1:22-cv-1028 through 3:20-cv-194.) (bgt) |
|
Thursday, September 19, 2024 | ||
6 | 6
order
Scheduling Order
Thu 09/19 2:59 PM
SCHEDULING ORDER ON DEFENDANTS' MOTION TO DISMISS. Signed by Judge Leigh Martin May on 09/19/2024.Associated Cases: 1:20-md-02974-LMM et al.(tht) |
|
Att: 1 Exhibit 1 | ||
Thursday, September 12, 2024 | ||
5 | 5
motion
Dismiss
Thu 09/12 6:28 PM
MOTION to Dismiss with Brief In Support by Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc., Teva Women's Health, LLC.(Ferrell, Pamela) |
|
Att: 1 Exhibit 1. List of Time Barred Complaints | ||
Monday, August 12, 2024 | ||
4 | 4
2
pgs
order
Order
Mon 08/12 11:25 AM
ORDER REGARDING DEFENDANTS' MOTION TO DISMISS. Signed by Judge Leigh Martin May on 08/12/2024.Associated Cases: 1:20-md-02974-LMM et al.(tht) |
|
Att: 1 Attachment to Order | ||
Tuesday, May 02, 2023 | ||
3 | 3
service
Waiver of Service Executed
Tue 05/02 3:43 PM
WAIVER OF SERVICE Returned Executed by Marilina Diaz. CooperSurgical, Inc waiver mailed on 4/27/2023, answer due 6/26/2023; Teva Branded Pharmaceutical Products R&D, Inc. waiver mailed on 4/27/2023, answer due 6/26/2023; Teva Pharmaceuticals USA, Inc. waiver mailed on 4/27/2023, answer due 6/26/2023; Teva Women's Health LLC waiver mailed on 4/27/2023, answer due 6/26/2023; The Cooper Companies, Inc. waiver mailed on 4/27/2023, answer due 6/26/2023. (Koo, Min) |
|
Friday, April 21, 2023 | ||
utility
Docket Correction
Fri 04/21 3:32 PM
Notification of Docket Correction re2 Order Modified to attach correct PDF. NEF has been regenerated. (kng) |
||
Tuesday, April 18, 2023 | ||
utility
Remark
Tue 04/18 4:41 PM
Remark: Counsel should review all Orders docketed in MDL Case No. 1:20-md-2974-LMM. The Court's Case Management Orders and other case-related documents can also be found on the Court's MDL web page: https://www.gand.uscourts.gov/20md2974 (bnp) |
||
Monday, April 17, 2023 | ||
2 | 2
7
pgs
order
Order
Tue 04/18 4:38 PM
ORDER INITIAL CONFERENCE: The Court held its Initial Conference in this MDL on February 9, 2021. The below are the orders entered after discussion of these issues at that conference. 1. Leadership structure: After the Court discussed issues concerning the leadership structure with all parties, the Court ORDERED Plaintiffs and Defendants to each file their proposed consent motion and order as to their requested leadership structure and team within 7 days of the date of this order. 2. Future status conferences: The Court will hold status conferences once a month. The next six conferences will take place on the following dates at 10:00 am via zoom: Tuesday, March 9, 2021; Monday, April 12, 2021; Wednesday, May 12, 2021; Monday, June 14, 2021; Tuesday, July 13, 2021; Friday, August 20, 2021. The Court will send out the zoom links prior to the conferences. The parties will submit a proposed consent agenda 3 business days prior to the conference. The parties will also confer as to the format for presenting issues that require additional explanation. When these are necessary, they should also be filed 3 business days before the conference. 3. Stay of responsive pleading obligations: The Court continues the stay of responsive pleading obligations provided for in Section 6(b) of the Court's initial order. 4. Pending motions: The Court DENIES WITHOUT PREJUDICE all pending motions in the individual cases comprising the MDL. These cases are also ADMINISTRATIVELY CLOSED. These terminated motions will later be refiled in accordance with an upcoming Case Management Order. 5. Docketing: All parties are to docket future filings only in the MDL case. The case caption should indicate whether any filing applies to all cases or list the individual cases to which it should apply. 6. Electronic service: The Court ORDERS all attorneys participating in the MDL proceeding to register with the Court's CM/ECF system. Because all attorneys will then receive electronic copies of documents filed in the MDL, the Court ORDERS that electronic service of documents via the Court's CM/ECF system satisfies the obligation of service. Hereafter, unless otherwise ordered, neither the clerk's office nor counsel for the parties shall be obligated to provide service copies of any filings or related orders by U.S. Mail or any other means to attorneys who have not registered with the Court's CM/ECF system. An attorney who is not participating in the MDL and does not want to receive CM/ECF notifications may file a motion to withdraw or a certificate of consent to withdraw in accordance with Local Rule 83.1(E). 7. Initial disclosures: The Court GRANTS the parties' joint request for the Court to excuse the parties from Rule 26(f) initial disclosures; except as to the ParaGard New Drug Application (NDA) that was transferred on or about November 10, 2005, to Duramed Pharmaceuticals, Inc., and produced by TWH, Inc., to plaintiff in the Estrada case. 8. Case management and initial orders: The parties are ORDERED to confer as to proposed orders for the list found herein. See order for further specifics and instructions. Signed by Judge Leigh Martin May on 02/10/2021.(kng) |
|
Att: 1 Civil Cover Sheet | ||
1 | 1
7
pgs
cmp
Complaint
Tue 04/18 4:36 PM
SHORT FORM COMPLAINT with Jury Demand filed by Marilina Diaz. Direct File MDL-USDC Northern District of Illinois Chicago Division. (Filing fee $402, receipt number AGANDC-12534382)(kng) Please visit our website at http://www.gand.uscourts.gov/commonly-used-forms to obtain Pretrial Instructions and Pretrial Associated Forms which includes the Consent To Proceed Before U.S. Magistrate form. |
|
Att: 1 Civil Cover Sheet | ||
utility
Terminate Civil Case
Tue 04/18 4:39 PM
Civil Case Terminated. (kng) |